Nexxen Q1 Results Validate SPO Isolation; Thesis Moves to Execution Phase

What happened

Nexxen reported Q1 2026 results, which management indicated were in line with expectations and reiterated that the Q4'25 DSP-driven revenue disruption was confined to that quarter. Programmatic revenue grew year-over-year in Q1, supporting the company's guidance of $367M–$381M for FY2026. The call confirmed that the key customer's spend has recovered, removing the primary near-term thesis risk. Additionally, management noted early traction with Nexxen TV and smart TV home screen PMPs, laying groundwork for CTV growth. The results align with the DeepValue report's base case, suggesting the stock's depressed valuation (EV/EBITDA ~3.2x) can re-rate if execution continues.

Implication

The Q1 print eliminates the near-term downside risk that the DSP partner's supply path optimization would persist into 2026. With guidance reiterated and programmatic revenue growth resumed, the base-case valuation of $8.60 is achievable. However, the stock has already recovered to $7.20, leaving limited upside without additional catalysts such as CTV product acceleration or completion of the non-core performance business restructuring. Investors should monitor quarterly cadence and evidence of multi-agency adoption of Nexxen TV products. A re-assessment in 3-6 months is warranted to confirm that growth is broad-based and not reliant on a single DSP recovery.

Thesis delta

Pre-call uncertainty about the extent of the SPO impact has been resolved in management's favor, shifting the thesis from 'validation risk' to 'execution risk.' The key question now is whether Nexxen can sustain programmatic growth through its own DSP and data platform, rather than relying on a third-party partner. The stock's re-rating potential depends on demonstrated CTV product adoption and stabilization of the non-core performance business.